Skip to content
DeepViews

PROTO LABS, INC. (PRLB) — Analysis Summary

PROTO LABS, INC. (PRLB) has a market cap of $2.19B with year-over-year revenue growth of +6.4%. Net margin stands at 4.0%. The stock trades at a P/E ratio of 71.9.

Key Takeaways

  • Revenue changed +6.4% year-over-year
  • Net margin of 4.0%
  • P/E ratio of 71.9

Compared to other companies in the FABRICATED STRUCTURAL METAL PRODUCTS sector, PRLB posted revenue growth of +6.4% and trades at a P/E of 71.9.

[XNYS]

PROTO LABS, INC. (PRLB)

$91.60

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$2191.25M
Enterprise Value
$2048.47M
P/E Ratio
71.9
Div Yield
0.00%
EV/EBITDA
29.5
Company Profile
About
About PROTO LABS, INC.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

Sector

FABRICATED STRUCTURAL METAL PRODUCTS

Employees

2,280

Headquarters

Maple Plain, MN

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
45
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$691.73M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$127.92M

Cash Flow

Operating Cash Flow$78.52M
Free Cash Flow$56.66M
FCF Margin10.11%
P/FCF Ratio38.67
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.